The puncta enigma.

08:00 EDT 14th August 2017 | BioPortfolio

Summary of "The puncta enigma."

This Editor's Corner may sound like the title of a mystery novel, but it actually reflects a question I have about the puncta articles that appear in Autophagy. In particular, I am surprised by the number of solicitations sent out for puncta that are either ignored, or, less frequently, declined. It is not that I expect the principal investigator (PI) to find the invitation to write a punctum undeniably attractive. Rather, it is the unilateral decision that it is not worthwhile for graduate students or postdocs who performed the work---and likely wrote at least the first draft of the paper---to write the punctum. In fact, time spent drafting a punctum yields considerable benefits: puncta provide more exposure for the lab, offer opportunities for young scientists to gain additional writing experience, and make a nice (albeit small) addition to a curriculum vitae. It is for the latter reason that I find it particularly disappointing that PIs decide to dismiss the opportunity to write a punctum. I fully understand that for many PIs, adding a punctum will not have a significant impact on a curriculum vitae. Yet for a student or a postdoc who might have a relatively small number of publications at this stage of their career, a punctum (though not a full-fledged research article) can have a more meaningful impact on their C.V.


Journal Details

This article was published in the following journal.

Name: Autophagy
ISSN: 1554-8635
Pages: 0


DeepDyve research library

PubMed Articles [76 Associated PubMed Articles listed on BioPortfolio]

The Modern Rehabilitation Medicine Enigma: Treating People with Disabilities, but Sometimes without a Clear Diagnosis.

The process of a comprehensive rehabilitation of the disabled person may be more complicated when the diagnosis becomes vague and uncertain. Unknown data about the patient's past, mental, physical or ...

Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium.

The profile of cortical neuroanatomical abnormalities in schizophrenia is not fully understood, despite hundreds of published structural brain imaging studies. This study presents the first meta-analy...

The enigma of demonetization and the unexplored consequences.

School Refusal Behavior: An Enigma Still To Be Resolved.

Race and Atrial Fibrillation: A Riddle, Wrapped in a Mystery, Inside an Enigma.

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

The ENIGMA Study: Eastern Inflammatory Bowel Disease Gut Microbiota

The incidence of inflammatory bowel diseases, (IBD) including Crohn's disease (CD) and ulcerative colitis (UC), is increasing in the developing world. Our recent Asia-Pacific population-ba...

A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)

The study objective is to compare IOP and safety outcomes based on plug placement (upper or lower puncta).

ENIGMA - Evaluation of Nitrous Oxide In the Gas Mixture for Anaesthesia: a Randomised Controlled Trial

We aim to investigate the effectiveness and safety of nitrous oxide (N2O) in anaesthesia. Hypothesis In patients undergoing anaesthesia for major surgery, avoidance of N2O will reduce ho...

Prevention of Docetaxel Induced Dacryostenosis

The antineoplastic agent Docetaxel (Taxotere®) is approved for the treatment of patients with metastatic and locally advanced breast cancer and other malignancies. There are 2 frequently ...

Duality of Lipids: the Athlete's Paradox

Accumulation of intramyocellular lipids (IMCLs) due to increased supply of fatty acids can induce defects in the insulin signaling cascade, causing skeletal muscle insulin resistance. Howe...

Medical and Biotech [MESH] Definitions

None available.

Quick Search


DeepDyve research library

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Searches Linking to this Article